# GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis

> **NCT01128738** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 152 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** GSK1358820
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01128738
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128738, "GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01128738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*